GSK3B and Hyperglycemia: Selective loss of GSK-3β in skeletal muscle improves glucose tolerance and insulin signaling, while removal of this isoform in β-islet cells can reduce hyperglycaemia in diabetic IRS-2 KO mice [12], [13].